|
Volumn 258, Issue 4, 2001, Pages 177-183
|
The dilemma of follow-up in head and neck cancer patients
a a a |
Author keywords
Curable recurrences; Follow up concepts; Head and neck cancer; Survival
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ARTICLE;
CANCER ADJUVANT THERAPY;
CANCER GROWTH;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CANCER STAGING;
CANCER SURGERY;
CLINICAL EXAMINATION;
CLINICAL FEATURE;
CLINICAL PROTOCOL;
CONTROLLED STUDY;
FOLLOW UP;
HEAD AND NECK CARCINOMA;
HUMAN;
LARYNX CARCINOMA;
MAJOR CLINICAL STUDY;
METASTASIS;
MOUTH CARCINOMA;
NECK METASTASIS;
PHARYNX CARCINOMA;
PRIORITY JOURNAL;
PROGNOSIS;
PSYCHOSOCIAL CARE;
RECURRENT CANCER;
SECOND CANCER;
SQUAMOUS CELL CARCINOMA;
TREATMENT OUTCOME;
AFTERCARE;
CARCINOMA, SQUAMOUS CELL;
COMBINED MODALITY THERAPY;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
LYMPHATIC METASTASIS;
MALE;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
OTORHINOLARYNGOLOGIC NEOPLASMS;
RETREATMENT;
RETROSPECTIVE STUDIES;
SURVIVAL RATE;
|
EID: 0035024558
PISSN: 09374477
EISSN: None
Source Type: Journal
DOI: 10.1007/s004050100333 Document Type: Article |
Times cited : (83)
|
References (11)
|